

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit biogenesis (GO:0042274) | 6.11926366 |
| 2 | DNA deamination (GO:0045006) | 5.73190244 |
| 3 | signal peptide processing (GO:0006465) | 4.34836603 |
| 4 | maturation of SSU-rRNA (GO:0030490) | 4.22797524 |
| 5 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.00461616 |
| 6 | viral life cycle (GO:0019058) | 3.96838854 |
| 7 | mitochondrial calcium ion transport (GO:0006851) | 3.86964814 |
| 8 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.73804431 |
| 9 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.73804431 |
| 10 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.69257029 |
| 11 | proteasome assembly (GO:0043248) | 3.61713807 |
| 12 | cellular protein complex disassembly (GO:0043624) | 3.61037295 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.58521625 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 3.57670494 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 3.50908899 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.50908899 |
| 17 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.49632481 |
| 18 | respiratory chain complex IV assembly (GO:0008535) | 3.43890533 |
| 19 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.39334183 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.38821035 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 3.38821035 |
| 22 | valine metabolic process (GO:0006573) | 3.36856496 |
| 23 | translational initiation (GO:0006413) | 3.36276643 |
| 24 | ATP synthesis coupled proton transport (GO:0015986) | 3.35635960 |
| 25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.35635960 |
| 26 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.34828477 |
| 27 | cysteine metabolic process (GO:0006534) | 3.31470493 |
| 28 | protein targeting to mitochondrion (GO:0006626) | 3.22866055 |
| 29 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.18690730 |
| 30 | COPI coating of Golgi vesicle (GO:0048205) | 3.16320369 |
| 31 | Golgi transport vesicle coating (GO:0048200) | 3.16320369 |
| 32 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.12536689 |
| 33 | cytochrome complex assembly (GO:0017004) | 3.12117480 |
| 34 | GDP-mannose metabolic process (GO:0019673) | 3.12074121 |
| 35 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.11370790 |
| 36 | chaperone-mediated protein transport (GO:0072321) | 3.10669844 |
| 37 | protein complex disassembly (GO:0043241) | 3.09982194 |
| 38 | branched-chain amino acid catabolic process (GO:0009083) | 3.08045537 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.06246004 |
| 40 | NADH metabolic process (GO:0006734) | 3.05199844 |
| 41 | cotranslational protein targeting to membrane (GO:0006613) | 3.05162479 |
| 42 | respiratory electron transport chain (GO:0022904) | 3.04653783 |
| 43 | protein targeting to ER (GO:0045047) | 3.04438755 |
| 44 | oxidative phosphorylation (GO:0006119) | 3.03964635 |
| 45 | serine family amino acid biosynthetic process (GO:0009070) | 3.03394109 |
| 46 | protein targeting to membrane (GO:0006612) | 2.99761254 |
| 47 | deoxyribonucleotide catabolic process (GO:0009264) | 2.98040791 |
| 48 | protein localization to endoplasmic reticulum (GO:0070972) | 2.97933642 |
| 49 | aromatic amino acid family catabolic process (GO:0009074) | 2.96000461 |
| 50 | electron transport chain (GO:0022900) | 2.95676614 |
| 51 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.94700485 |
| 52 | deoxyribose phosphate catabolic process (GO:0046386) | 2.93784149 |
| 53 | folic acid metabolic process (GO:0046655) | 2.90717254 |
| 54 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.90523910 |
| 55 | establishment of protein localization to mitochondrion (GO:0072655) | 2.90397890 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 2.89919292 |
| 57 | protein complex biogenesis (GO:0070271) | 2.89709556 |
| 58 | macromolecular complex disassembly (GO:0032984) | 2.89093655 |
| 59 | GTP biosynthetic process (GO:0006183) | 2.88455314 |
| 60 | cellular component biogenesis (GO:0044085) | 2.87286355 |
| 61 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.85592290 |
| 62 | rRNA modification (GO:0000154) | 2.84040559 |
| 63 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.83010370 |
| 64 | regulation of mitochondrial translation (GO:0070129) | 2.82496935 |
| 65 | UTP biosynthetic process (GO:0006228) | 2.81940866 |
| 66 | ribosomal large subunit biogenesis (GO:0042273) | 2.81209394 |
| 67 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.80657570 |
| 68 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.80657570 |
| 69 | NADH dehydrogenase complex assembly (GO:0010257) | 2.80657570 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79750594 |
| 71 | peptidyl-histidine modification (GO:0018202) | 2.78955057 |
| 72 | purine nucleotide salvage (GO:0032261) | 2.78081347 |
| 73 | iron-sulfur cluster assembly (GO:0016226) | 2.77589690 |
| 74 | metallo-sulfur cluster assembly (GO:0031163) | 2.77589690 |
| 75 | proline biosynthetic process (GO:0006561) | 2.75543699 |
| 76 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.75099436 |
| 77 | sulfur amino acid catabolic process (GO:0000098) | 2.74382569 |
| 78 | tryptophan metabolic process (GO:0006568) | 2.74138531 |
| 79 | glyoxylate metabolic process (GO:0046487) | 2.73928572 |
| 80 | glycine metabolic process (GO:0006544) | 2.73827761 |
| 81 | protein localization to mitochondrion (GO:0070585) | 2.73056749 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.71004152 |
| 83 | amino acid salvage (GO:0043102) | 2.70840888 |
| 84 | L-methionine salvage (GO:0071267) | 2.70840888 |
| 85 | L-methionine biosynthetic process (GO:0071265) | 2.70840888 |
| 86 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70060370 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70060370 |
| 88 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.67890687 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 2.67272057 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 2.65612710 |
| 91 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.65522480 |
| 92 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.65052774 |
| 93 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.64544478 |
| 94 | pentose metabolic process (GO:0019321) | 2.64056995 |
| 95 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.63357083 |
| 96 | formation of translation preinitiation complex (GO:0001731) | 2.62710482 |
| 97 | proline metabolic process (GO:0006560) | 2.62480682 |
| 98 | purine-containing compound salvage (GO:0043101) | 2.62038983 |
| 99 | protein retention in ER lumen (GO:0006621) | 2.61815561 |
| 100 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.61176202 |
| 101 | tryptophan catabolic process (GO:0006569) | 2.61148088 |
| 102 | indole-containing compound catabolic process (GO:0042436) | 2.61148088 |
| 103 | indolalkylamine catabolic process (GO:0046218) | 2.61148088 |
| 104 | ncRNA 3-end processing (GO:0043628) | 2.60256967 |
| 105 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59789016 |
| 106 | L-serine metabolic process (GO:0006563) | 2.59657179 |
| 107 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.59303441 |
| 108 | CTP metabolic process (GO:0046036) | 2.59207143 |
| 109 | CTP biosynthetic process (GO:0006241) | 2.59207143 |
| 110 | sulfur amino acid biosynthetic process (GO:0000097) | 2.56635257 |
| 111 | deoxyribose phosphate metabolic process (GO:0019692) | 2.56613390 |
| 112 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.56127162 |
| 113 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.56125689 |
| 114 | translation (GO:0006412) | 2.56116445 |
| 115 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.55788262 |
| 116 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.55002839 |
| 117 | mitochondrial transport (GO:0006839) | 2.52427247 |
| 118 | UTP metabolic process (GO:0046051) | 2.51741596 |
| 119 | cellular metabolic compound salvage (GO:0043094) | 2.51668955 |
| 120 | aromatic amino acid family metabolic process (GO:0009072) | 2.51418122 |
| 121 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.51315814 |
| 122 | translational termination (GO:0006415) | 2.50605319 |
| 123 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.49845721 |
| 124 | termination of RNA polymerase III transcription (GO:0006386) | 2.49845721 |
| 125 | viral transcription (GO:0019083) | 2.49757576 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.47931778 |
| 127 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.47408230 |
| 128 | regulation of necrotic cell death (GO:0010939) | 2.46852091 |
| 129 | regulation of mitochondrial membrane potential (GO:0051881) | 2.46732799 |
| 130 | exocrine pancreas development (GO:0031017) | 2.46404604 |
| 131 | response to interferon-beta (GO:0035456) | 2.46191936 |
| 132 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.44428610 |
| 133 | rRNA methylation (GO:0031167) | 2.44083166 |
| 134 | purine nucleobase biosynthetic process (GO:0009113) | 2.44011307 |
| 135 | GMP metabolic process (GO:0046037) | 2.43871438 |
| 136 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.42924797 |
| 137 | nucleotide-sugar metabolic process (GO:0009225) | 2.42572618 |
| 138 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.41922390 |
| 139 | pteridine-containing compound metabolic process (GO:0042558) | 2.41284565 |
| 140 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.41104287 |
| 141 | rRNA processing (GO:0006364) | 2.40923454 |
| 142 | nucleoside salvage (GO:0043174) | 2.40563336 |
| 143 | bile acid biosynthetic process (GO:0006699) | 2.40064354 |
| 144 | aerobic respiration (GO:0009060) | 2.38708924 |
| 145 | ribosome biogenesis (GO:0042254) | 2.38458705 |
| 146 | COPII vesicle coating (GO:0048208) | 2.38395280 |
| 147 | protein maturation by protein folding (GO:0022417) | 2.37641680 |
| 148 | pantothenate metabolic process (GO:0015939) | 2.37499059 |
| 149 | base-excision repair, AP site formation (GO:0006285) | 2.36733859 |
| 150 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.34594851 |
| 151 | nucleotide salvage (GO:0043173) | 2.34197968 |
| 152 | pseudouridine synthesis (GO:0001522) | 2.33917619 |
| 153 | quinone biosynthetic process (GO:1901663) | 2.33619251 |
| 154 | ubiquinone biosynthetic process (GO:0006744) | 2.33619251 |
| 155 | S-adenosylmethionine metabolic process (GO:0046500) | 2.33596474 |
| 156 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.33426000 |
| 157 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.32396808 |
| 158 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.30819988 |
| 159 | aldehyde catabolic process (GO:0046185) | 2.30128753 |
| 160 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.28745769 |
| 161 | translational elongation (GO:0006414) | 2.27936139 |
| 162 | nucleobase biosynthetic process (GO:0046112) | 2.26990574 |
| 163 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.26525065 |
| 164 | fatty acid beta-oxidation (GO:0006635) | 2.25113419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.77976969 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.32137842 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.31624436 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.22250096 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.13299877 |
| 6 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.93825107 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.91612735 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.79597606 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.77354021 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.70373077 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.69118044 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.61847755 |
| 13 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.58645326 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53329432 |
| 15 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52880520 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41791084 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41485731 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.38358495 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.36068695 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.33254412 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.31833053 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.31769299 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.28866906 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.25839665 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25363193 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.21548996 |
| 27 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11280183 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07624702 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05943739 |
| 30 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.05271496 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.03510126 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.02004884 |
| 33 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.00882894 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.00783579 |
| 35 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00204391 |
| 36 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.96531647 |
| 37 | * MYC_22102868_ChIP-Seq_BL_Human | 1.96230698 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.93072962 |
| 39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92557404 |
| 40 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.91683519 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90629795 |
| 42 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.87583307 |
| 43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.81078854 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73924619 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73043584 |
| 46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71647140 |
| 47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.68834142 |
| 48 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66253369 |
| 49 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.65005387 |
| 50 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.61672348 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60739975 |
| 52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.59814806 |
| 53 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59054584 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58726924 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57370134 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56163838 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54347150 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52927432 |
| 59 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50128678 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47212470 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45935174 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44603553 |
| 63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44213203 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43199437 |
| 65 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.43167134 |
| 66 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.42716950 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40723520 |
| 68 | * MAF_26560356_Chip-Seq_TH2_Human | 1.40289002 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.39640737 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39184194 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.39048966 |
| 72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38247432 |
| 73 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38210739 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37529471 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.36547736 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.35846720 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35067920 |
| 78 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33774231 |
| 79 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32022670 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30450595 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29374303 |
| 82 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27345546 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.26015692 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23457706 |
| 85 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22162799 |
| 86 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21526742 |
| 87 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20726671 |
| 88 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20526272 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20346660 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18569360 |
| 91 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.17776407 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16250176 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15816757 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15025809 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14744485 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13817146 |
| 97 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.13133396 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12676406 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12372404 |
| 100 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.12119174 |
| 101 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10599976 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10124158 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08850446 |
| 104 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08274508 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07201297 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06945899 |
| 107 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06500385 |
| 108 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05944258 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04840192 |
| 110 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04771100 |
| 111 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02728643 |
| 112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00837303 |
| 113 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00441091 |
| 114 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99803741 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98652319 |
| 116 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97958563 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97608419 |
| 118 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97081317 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96981460 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96432854 |
| 121 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.95417964 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94294698 |
| 123 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92604677 |
| 124 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.92337955 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92265928 |
| 126 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91122792 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90073759 |
| 128 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89808035 |
| 129 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89756893 |
| 130 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.89719341 |
| 131 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.89558077 |
| 132 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88831562 |
| 133 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88173425 |
| 134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86950987 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84470409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.97883048 |
| 2 | MP0005365_abnormal_bile_salt | 3.70421685 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.32173517 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.11209987 |
| 5 | MP0005360_urolithiasis | 3.03255432 |
| 6 | MP0005083_abnormal_biliary_tract | 2.94385845 |
| 7 | MP0009840_abnormal_foam_cell | 2.60439253 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.56092557 |
| 9 | MP0003186_abnormal_redox_activity | 2.51633838 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45531115 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.25486264 |
| 12 | MP0003195_calcinosis | 2.21745160 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.14561965 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.07017064 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.05655823 |
| 16 | MP0005451_abnormal_body_composition | 1.98939555 |
| 17 | MP0005671_abnormal_response_to | 1.92642188 |
| 18 | MP0001873_stomach_inflammation | 1.92601521 |
| 19 | MP0005332_abnormal_amino_acid | 1.91765706 |
| 20 | MP0000685_abnormal_immune_system | 1.82028416 |
| 21 | MP0003693_abnormal_embryo_hatching | 1.79966148 |
| 22 | MP0001764_abnormal_homeostasis | 1.79662580 |
| 23 | MP0009697_abnormal_copulation | 1.78447721 |
| 24 | MP0002163_abnormal_gland_morphology | 1.74370770 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.70974842 |
| 26 | MP0009785_altered_susceptibility_to | 1.70188082 |
| 27 | MP0003252_abnormal_bile_duct | 1.66554522 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.63204036 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.61742350 |
| 30 | MP0003303_peritoneal_inflammation | 1.58082573 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.57848655 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.55271471 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.55201385 |
| 34 | MP0003436_decreased_susceptibility_to | 1.55001027 |
| 35 | MP0004147_increased_porphyrin_level | 1.49795015 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.49733391 |
| 37 | MP0001853_heart_inflammation | 1.48772652 |
| 38 | MP0002693_abnormal_pancreas_physiology | 1.47449526 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.44409562 |
| 40 | MP0000609_abnormal_liver_physiology | 1.43694925 |
| 41 | MP0008469_abnormal_protein_level | 1.42969290 |
| 42 | MP0005025_abnormal_response_to | 1.42625371 |
| 43 | MP0008260_abnormal_autophagy | 1.41196192 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.36190340 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.33951507 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.31341982 |
| 47 | MP0003868_abnormal_feces_composition | 1.29286568 |
| 48 | MP0000681_abnormal_thyroid_gland | 1.28650783 |
| 49 | MP0004947_skin_inflammation | 1.28222841 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.28165024 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.28135573 |
| 52 | MP0002132_abnormal_respiratory_system | 1.27995487 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.27340674 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.27249204 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.27050548 |
| 56 | MP0005501_abnormal_skin_physiology | 1.25601298 |
| 57 | MP0004043_abnormal_pH_regulation | 1.23756149 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.22138374 |
| 59 | MP0000490_abnormal_crypts_of | 1.21860047 |
| 60 | MP0001800_abnormal_humoral_immune | 1.20503803 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.19575870 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.18663159 |
| 63 | MP0002723_abnormal_immune_serum | 1.18477626 |
| 64 | MP0004858_abnormal_nervous_system | 1.16976935 |
| 65 | MP0002419_abnormal_innate_immunity | 1.16579110 |
| 66 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16543729 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.16296686 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.15852008 |
| 69 | MP0001944_abnormal_pancreas_morphology | 1.14482699 |
| 70 | MP0000343_altered_response_to | 1.14185512 |
| 71 | MP0003075_altered_response_to | 1.13788332 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.13121205 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 1.12677954 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.12470980 |
| 75 | MP0005387_immune_system_phenotype | 1.11616518 |
| 76 | MP0001790_abnormal_immune_system | 1.11616518 |
| 77 | MP0002796_impaired_skin_barrier | 1.11002189 |
| 78 | MP0003718_maternal_effect | 1.10904707 |
| 79 | MP0009278_abnormal_bone_marrow | 1.10880093 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.10187298 |
| 81 | MP0008058_abnormal_DNA_repair | 1.10024069 |
| 82 | MP0002452_abnormal_antigen_presenting | 1.08927022 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.07746512 |
| 84 | MP0002420_abnormal_adaptive_immunity | 1.04356623 |
| 85 | MP0002019_abnormal_tumor_incidence | 1.04028971 |
| 86 | MP0000689_abnormal_spleen_morphology | 1.03416996 |
| 87 | MP0001881_abnormal_mammary_gland | 1.02889181 |
| 88 | MP0001819_abnormal_immune_cell | 1.01703390 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 1.01618752 |
| 90 | MP0005379_endocrine/exocrine_gland_phen | 1.01581527 |
| 91 | MP0005166_decreased_susceptibility_to | 1.01493761 |
| 92 | MP0001533_abnormal_skeleton_physiology | 1.00801148 |
| 93 | MP0003123_paternal_imprinting | 1.00728736 |
| 94 | MP0001661_extended_life_span | 0.99960436 |
| 95 | MP0000313_abnormal_cell_death | 0.99140213 |
| 96 | MP0000598_abnormal_liver_morphology | 0.97828074 |
| 97 | MP0003724_increased_susceptibility_to | 0.97108320 |
| 98 | MP0000716_abnormal_immune_system | 0.95926933 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.95830306 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 0.93587081 |
| 101 | MP0002398_abnormal_bone_marrow | 0.93545402 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.92648507 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.92320753 |
| 104 | MP0005670_abnormal_white_adipose | 0.92028383 |
| 105 | MP0003111_abnormal_nucleus_morphology | 0.89983497 |
| 106 | MP0000604_amyloidosis | 0.88527994 |
| 107 | MP0003866_abnormal_defecation | 0.88381560 |
| 108 | MP0009763_increased_sensitivity_to | 0.88184565 |
| 109 | MP0004957_abnormal_blastocyst_morpholog | 0.87624534 |
| 110 | MP0002006_tumorigenesis | 0.87597341 |
| 111 | MP0002722_abnormal_immune_system | 0.87445908 |
| 112 | MP0002405_respiratory_system_inflammati | 0.87255149 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.87021443 |
| 114 | MP0002429_abnormal_blood_cell | 0.86846926 |
| 115 | MP0006082_CNS_inflammation | 0.86758738 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.86387928 |
| 117 | MP0000858_altered_metastatic_potential | 0.84943014 |
| 118 | MP0001663_abnormal_digestive_system | 0.83836251 |
| 119 | MP0009764_decreased_sensitivity_to | 0.83255981 |
| 120 | MP0000613_abnormal_salivary_gland | 0.81824600 |
| 121 | MP0002876_abnormal_thyroid_physiology | 0.79869889 |
| 122 | MP0003077_abnormal_cell_cycle | 0.79832239 |
| 123 | MP0003786_premature_aging | 0.79560994 |
| 124 | MP0001756_abnormal_urination | 0.79419148 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.77955464 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.77490590 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.77330358 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.77054930 |
| 129 | MP0001919_abnormal_reproductive_system | 0.76809350 |
| 130 | MP0002009_preneoplasia | 0.74992426 |
| 131 | MP0008007_abnormal_cellular_replicative | 0.74484893 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.74325002 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.72846748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.46611740 |
| 2 | Hepatic necrosis (HP:0002605) | 3.68133512 |
| 3 | Hepatocellular necrosis (HP:0001404) | 3.29428398 |
| 4 | Generalized aminoaciduria (HP:0002909) | 3.27073442 |
| 5 | Hypoglycemic coma (HP:0001325) | 3.26540689 |
| 6 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.21307534 |
| 7 | Dicarboxylic aciduria (HP:0003215) | 3.21307534 |
| 8 | Reduced antithrombin III activity (HP:0001976) | 3.16322554 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.14117807 |
| 10 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.06941170 |
| 11 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.99177055 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.96557836 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.96557836 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 2.93389584 |
| 15 | Obstructive lung disease (HP:0006536) | 2.93389584 |
| 16 | Ketosis (HP:0001946) | 2.91102665 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 2.89815778 |
| 18 | Hyperglycinuria (HP:0003108) | 2.87857237 |
| 19 | Increased muscle lipid content (HP:0009058) | 2.85577206 |
| 20 | Increased intramyocellular lipid droplets (HP:0012240) | 2.81259236 |
| 21 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.80118116 |
| 22 | Abnormal protein glycosylation (HP:0012346) | 2.80118116 |
| 23 | Abnormal glycosylation (HP:0012345) | 2.80118116 |
| 24 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.80118116 |
| 25 | Mitochondrial inheritance (HP:0001427) | 2.77129077 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 2.75678660 |
| 27 | Abnormal number of erythroid precursors (HP:0012131) | 2.75598005 |
| 28 | Hypertensive crisis (HP:0100735) | 2.75125626 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.74770949 |
| 30 | Hyperglycinemia (HP:0002154) | 2.74039672 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.72305137 |
| 32 | Vertebral compression fractures (HP:0002953) | 2.70842941 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.70666902 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 2.69797659 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.67688716 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67688716 |
| 37 | Acute encephalopathy (HP:0006846) | 2.67538038 |
| 38 | Ketoacidosis (HP:0001993) | 2.64484305 |
| 39 | Increased CSF lactate (HP:0002490) | 2.64365218 |
| 40 | Increased serum ferritin (HP:0003281) | 2.62668680 |
| 41 | Purpura (HP:0000979) | 2.62169627 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.60484747 |
| 43 | Macrocytic anemia (HP:0001972) | 2.60172310 |
| 44 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.60099280 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.58131248 |
| 46 | Lactic acidosis (HP:0003128) | 2.57237169 |
| 47 | Lethargy (HP:0001254) | 2.55845114 |
| 48 | Gout (HP:0001997) | 2.55562974 |
| 49 | Eczematoid dermatitis (HP:0000976) | 2.55464309 |
| 50 | Cerebral edema (HP:0002181) | 2.54580320 |
| 51 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.54186904 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53391673 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53391673 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53391673 |
| 55 | Nausea (HP:0002018) | 2.52986570 |
| 56 | Methylmalonic aciduria (HP:0012120) | 2.52469228 |
| 57 | Delayed CNS myelination (HP:0002188) | 2.52351216 |
| 58 | Increased serum lactate (HP:0002151) | 2.50995883 |
| 59 | Hypobetalipoproteinemia (HP:0003563) | 2.49145505 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.49080216 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.48745803 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.48376231 |
| 63 | Glycosuria (HP:0003076) | 2.48376231 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47954376 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.46396411 |
| 66 | Progressive muscle weakness (HP:0003323) | 2.44567482 |
| 67 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.44535581 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.44300338 |
| 69 | IgM deficiency (HP:0002850) | 2.41998135 |
| 70 | Fat malabsorption (HP:0002630) | 2.40836654 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.40502552 |
| 72 | Renal Fanconi syndrome (HP:0001994) | 2.39704123 |
| 73 | Testicular atrophy (HP:0000029) | 2.39591070 |
| 74 | Hyperammonemia (HP:0001987) | 2.39504718 |
| 75 | Pallor (HP:0000980) | 2.36575198 |
| 76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35011277 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.32984090 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.32529797 |
| 79 | Abnormality of macrophages (HP:0004311) | 2.29252673 |
| 80 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27950297 |
| 81 | Steatorrhea (HP:0002570) | 2.26323281 |
| 82 | Xanthomatosis (HP:0000991) | 2.26153052 |
| 83 | Exertional dyspnea (HP:0002875) | 2.24538026 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.24092685 |
| 85 | Hyperalaninemia (HP:0003348) | 2.24092685 |
| 86 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.24092685 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23426062 |
| 88 | Pancytopenia (HP:0001876) | 2.23423109 |
| 89 | Aplastic anemia (HP:0001915) | 2.21758571 |
| 90 | Reticulocytopenia (HP:0001896) | 2.21528331 |
| 91 | Hyperthyroidism (HP:0000836) | 2.21207061 |
| 92 | Metabolic acidosis (HP:0001942) | 2.21031294 |
| 93 | Rough bone trabeculation (HP:0100670) | 2.20006490 |
| 94 | Recurrent bacterial skin infections (HP:0005406) | 2.19542729 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 2.18191294 |
| 96 | Abnormality of T cell physiology (HP:0011840) | 2.17535139 |
| 97 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.17440042 |
| 98 | Late onset (HP:0003584) | 2.17342274 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 2.16638538 |
| 100 | Respiratory failure (HP:0002878) | 2.14078267 |
| 101 | Seborrheic dermatitis (HP:0001051) | 2.11541374 |
| 102 | CNS demyelination (HP:0007305) | 2.10172976 |
| 103 | Increased IgM level (HP:0003496) | 2.09782855 |
| 104 | Meningitis (HP:0001287) | 2.09099244 |
| 105 | Microretrognathia (HP:0000308) | 2.08620008 |
| 106 | Progressive neurologic deterioration (HP:0002344) | 2.07854490 |
| 107 | Esophageal neoplasm (HP:0100751) | 2.07516890 |
| 108 | Neoplasm of head and neck (HP:0012288) | 2.07516890 |
| 109 | Colitis (HP:0002583) | 2.07364325 |
| 110 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.07020144 |
| 111 | Respiratory difficulties (HP:0002880) | 2.06183567 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 2.05098735 |
| 113 | Rhabdomyolysis (HP:0003201) | 2.04214824 |
| 114 | Exercise intolerance (HP:0003546) | 2.04112937 |
| 115 | Emotional lability (HP:0000712) | 2.03389719 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03149658 |
| 117 | Hyperbilirubinemia (HP:0002904) | 2.01680232 |
| 118 | Beaking of vertebral bodies (HP:0004568) | 1.99876118 |
| 119 | Poor head control (HP:0002421) | 1.98791506 |
| 120 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.98479070 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.97680466 |
| 122 | Megaloblastic anemia (HP:0001889) | 1.97301998 |
| 123 | Brushfield spots (HP:0001088) | 1.97035155 |
| 124 | Prolonged neonatal jaundice (HP:0006579) | 1.96441066 |
| 125 | Progressive macrocephaly (HP:0004481) | 1.95531938 |
| 126 | Petechiae (HP:0000967) | 1.94731489 |
| 127 | Thrombocytosis (HP:0001894) | 1.94421825 |
| 128 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94168110 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.93847462 |
| 130 | Dysostosis multiplex (HP:0000943) | 1.92638052 |
| 131 | Microcytic anemia (HP:0001935) | 1.92012826 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.91870805 |
| 133 | Cellulitis (HP:0100658) | 1.91730901 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91434854 |
| 135 | Hyperphosphaturia (HP:0003109) | 1.91347291 |
| 136 | Ragged-red muscle fibers (HP:0003200) | 1.91342994 |
| 137 | Hypoglycemic seizures (HP:0002173) | 1.91299960 |
| 138 | Recurrent viral infections (HP:0004429) | 1.91011514 |
| 139 | Hyperparathyroidism (HP:0000843) | 1.90112877 |
| 140 | Pancreatitis (HP:0001733) | 1.89984864 |
| 141 | Spastic paraparesis (HP:0002313) | 1.89889642 |
| 142 | Vomiting (HP:0002013) | 1.89823595 |
| 143 | Gastrointestinal inflammation (HP:0004386) | 1.89418625 |
| 144 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.89417594 |
| 145 | Cerebral palsy (HP:0100021) | 1.85048117 |
| 146 | Myopathic facies (HP:0002058) | 1.83176858 |
| 147 | Acute hepatic failure (HP:0006554) | 1.81353328 |
| 148 | Multiple enchondromatosis (HP:0005701) | 1.81115230 |
| 149 | Urticaria (HP:0001025) | 1.79439121 |
| 150 | Abnormal trabecular bone morphology (HP:0100671) | 1.76051876 |
| 151 | Loss of speech (HP:0002371) | 1.75843128 |
| 152 | Orthostatic hypotension (HP:0001278) | 1.75183238 |
| 153 | Inflammation of the large intestine (HP:0002037) | 1.72179228 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.71977723 |
| 155 | Truncus arteriosus (HP:0001660) | 1.69004719 |
| 156 | Skin rash (HP:0000988) | 1.68976591 |
| 157 | Granulocytopenia (HP:0001913) | 1.68785356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.75531414 |
| 2 | NME2 | 4.32355169 |
| 3 | BCKDK | 4.15859701 |
| 4 | ERN1 | 3.40131457 |
| 5 | TESK1 | 2.68916282 |
| 6 | TRIB3 | 2.63221210 |
| 7 | BUB1 | 2.60342218 |
| 8 | EIF2AK3 | 2.44761143 |
| 9 | MUSK | 2.06847305 |
| 10 | VRK2 | 2.03194829 |
| 11 | MAPK15 | 1.99605914 |
| 12 | PIM2 | 1.94102365 |
| 13 | WEE1 | 1.86187996 |
| 14 | TLK1 | 1.86017417 |
| 15 | PRPF4B | 1.82002375 |
| 16 | VRK1 | 1.78237060 |
| 17 | MAP4K1 | 1.76224640 |
| 18 | FLT3 | 1.71788054 |
| 19 | DYRK3 | 1.67986916 |
| 20 | TBK1 | 1.67568710 |
| 21 | SCYL2 | 1.65642950 |
| 22 | SMG1 | 1.65398230 |
| 23 | TYK2 | 1.61332301 |
| 24 | RPS6KA4 | 1.60979600 |
| 25 | TEC | 1.60251210 |
| 26 | ARAF | 1.57745439 |
| 27 | CAMKK2 | 1.56223911 |
| 28 | KIT | 1.56005504 |
| 29 | EIF2AK1 | 1.55796853 |
| 30 | IRAK3 | 1.52709105 |
| 31 | LIMK1 | 1.45452891 |
| 32 | ACVR1B | 1.43203121 |
| 33 | MAP2K3 | 1.43041742 |
| 34 | IKBKE | 1.41055754 |
| 35 | KDR | 1.40344064 |
| 36 | RIPK4 | 1.39532762 |
| 37 | MAP3K3 | 1.32800303 |
| 38 | ILK | 1.30926754 |
| 39 | ZAP70 | 1.30394976 |
| 40 | IRAK4 | 1.28143524 |
| 41 | MAPKAPK3 | 1.26224539 |
| 42 | NLK | 1.23685702 |
| 43 | PLK4 | 1.20542296 |
| 44 | BTK | 1.18739599 |
| 45 | TGFBR2 | 1.18268424 |
| 46 | MAP3K14 | 1.12792263 |
| 47 | TAOK3 | 1.12712029 |
| 48 | PIK3CG | 1.05729835 |
| 49 | PASK | 1.02047064 |
| 50 | NME1 | 1.01836155 |
| 51 | TESK2 | 1.00949738 |
| 52 | IKBKB | 1.00351606 |
| 53 | AURKA | 1.00078780 |
| 54 | BLK | 0.99361129 |
| 55 | BRSK2 | 0.95806637 |
| 56 | MAP3K12 | 0.94514765 |
| 57 | JAK3 | 0.93653522 |
| 58 | PKN2 | 0.91026739 |
| 59 | INSRR | 0.89686162 |
| 60 | SRPK1 | 0.88235984 |
| 61 | CSF1R | 0.87620222 |
| 62 | LRRK2 | 0.83796370 |
| 63 | PINK1 | 0.82849486 |
| 64 | MAP3K13 | 0.82712104 |
| 65 | MAP3K11 | 0.82483063 |
| 66 | MAP3K1 | 0.82379628 |
| 67 | TXK | 0.82242745 |
| 68 | CDK8 | 0.82097229 |
| 69 | SIK1 | 0.81138612 |
| 70 | BRAF | 0.77674542 |
| 71 | ZAK | 0.77347299 |
| 72 | PAK4 | 0.75738461 |
| 73 | RPS6KB2 | 0.75193390 |
| 74 | ABL2 | 0.74425699 |
| 75 | IRAK1 | 0.74415112 |
| 76 | DAPK1 | 0.74398420 |
| 77 | PBK | 0.73695250 |
| 78 | MST4 | 0.73530571 |
| 79 | EPHA2 | 0.71595475 |
| 80 | PDK2 | 0.70399258 |
| 81 | IRAK2 | 0.69421099 |
| 82 | SYK | 0.68764037 |
| 83 | MAPKAPK5 | 0.67340662 |
| 84 | FGFR4 | 0.67304109 |
| 85 | DAPK3 | 0.67303266 |
| 86 | FES | 0.66406103 |
| 87 | PIM1 | 0.65046850 |
| 88 | TIE1 | 0.63537159 |
| 89 | TAOK1 | 0.62764763 |
| 90 | MAP2K2 | 0.62317794 |
| 91 | PRKCI | 0.61739190 |
| 92 | PAK1 | 0.61665575 |
| 93 | PDPK1 | 0.59309565 |
| 94 | TNK2 | 0.58922406 |
| 95 | MAP3K8 | 0.57186863 |
| 96 | ICK | 0.56944838 |
| 97 | MAPK11 | 0.56688527 |
| 98 | STK10 | 0.56592892 |
| 99 | LYN | 0.55649770 |
| 100 | CDK19 | 0.54474927 |
| 101 | RPS6KA5 | 0.53798609 |
| 102 | EIF2AK2 | 0.52317313 |
| 103 | CDK7 | 0.52037887 |
| 104 | CCNB1 | 0.51661301 |
| 105 | MAP2K6 | 0.50490420 |
| 106 | HIPK2 | 0.50221344 |
| 107 | MST1R | 0.50193026 |
| 108 | MYLK | 0.48708548 |
| 109 | TNIK | 0.47849153 |
| 110 | NEK9 | 0.47520015 |
| 111 | EEF2K | 0.46327657 |
| 112 | CSK | 0.43922871 |
| 113 | TGFBR1 | 0.43329321 |
| 114 | MAP3K5 | 0.42808245 |
| 115 | RAF1 | 0.42588397 |
| 116 | JAK1 | 0.42534215 |
| 117 | PRKG2 | 0.42468759 |
| 118 | PRKD2 | 0.41637256 |
| 119 | CSNK2A1 | 0.41453738 |
| 120 | LCK | 0.41279961 |
| 121 | CDK4 | 0.40265814 |
| 122 | AURKB | 0.40255332 |
| 123 | GRK6 | 0.39910337 |
| 124 | FRK | 0.39739555 |
| 125 | CHUK | 0.39330354 |
| 126 | NEK1 | 0.38830883 |
| 127 | CAMK2G | 0.38549307 |
| 128 | CSNK2A2 | 0.37819471 |
| 129 | MAP3K7 | 0.37771537 |
| 130 | PDK1 | 0.35847876 |
| 131 | MAPKAPK2 | 0.35659118 |
| 132 | MAPK12 | 0.35234375 |
| 133 | OBSCN | 0.34237945 |
| 134 | PRKCD | 0.34028778 |
| 135 | AKT2 | 0.33701507 |
| 136 | ATR | 0.32361361 |
| 137 | HCK | 0.31080327 |
| 138 | TAOK2 | 0.30481746 |
| 139 | BMPR2 | 0.30058084 |
| 140 | MAPK4 | 0.29859115 |
| 141 | GRK1 | 0.29716019 |
| 142 | JAK2 | 0.29606245 |
| 143 | RPS6KL1 | 0.27989806 |
| 144 | RPS6KC1 | 0.27989806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.50191785 |
| 2 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.86925081 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.44132210 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.32798057 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.22861524 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.19432727 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.09993452 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07220633 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98262189 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.95781539 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.92685761 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.90799668 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.90528253 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84824585 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82731616 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.77239139 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75406514 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.75295915 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.69659366 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65041384 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.61673419 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.58646704 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58042645 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.57833292 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.52621740 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51538954 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47812335 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47386041 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.45904248 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.40671362 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39833064 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.38855503 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38652915 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.38385260 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36596411 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36200574 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31868420 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27260833 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.27156891 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26666147 |
| 41 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23581361 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23182864 |
| 43 | Mismatch repair_Homo sapiens_hsa03430 | 1.21300959 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19289304 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13841999 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.13821538 |
| 47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12823779 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11243764 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09988010 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06393724 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05937676 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01579450 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01048987 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00233253 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99981543 |
| 56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99626474 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.99034941 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98660138 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.97739205 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97503557 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97321672 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96662430 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96265300 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94544407 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94306114 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93859020 |
| 67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93782472 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93097898 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92214113 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92103178 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91611741 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91228561 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89518065 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89375522 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88175794 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.87495978 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86602556 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86466284 |
| 79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86289940 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86284760 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.86157165 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85988701 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85594447 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85524316 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.85448466 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.84252942 |
| 87 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79990837 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79918211 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77537672 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76790887 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76595143 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76552636 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75875316 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75535824 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70101402 |
| 96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70039516 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.69924992 |
| 98 | Spliceosome_Homo sapiens_hsa03040 | 0.69086011 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67683149 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67505604 |
| 101 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67130660 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66919815 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.64870338 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64560011 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64300375 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64220702 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64099693 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.61868618 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.61756843 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60444333 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.59438404 |
| 112 | Tuberculosis_Homo sapiens_hsa05152 | 0.58810074 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.55120019 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54176080 |
| 115 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53928501 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53751277 |
| 117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53311449 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53158905 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53088804 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52438466 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52051598 |
| 122 | RNA transport_Homo sapiens_hsa03013 | 0.50325125 |
| 123 | RNA degradation_Homo sapiens_hsa03018 | 0.49623130 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.49340708 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.49184997 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.46468434 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45868062 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.45452651 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45257595 |
| 130 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45016546 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.43682223 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43502268 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43229904 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42618965 |
| 135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42051331 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40974565 |
| 137 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40068914 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36560771 |
| 139 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35577793 |

